SQY Therapeutics
Designing genetic disease treatments
- B2B
About SQY Therapeutics
A French biotechnology company specializing in designing and producing tricyclo-DNA antisense oligonucleotides for R&D programs targeting genetic diseases, specifically neuromuscular diseases
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Guyancourt, Île-de-France, France
- Founded
- 2015
- Revenue
- $5.8M – $46.1MTamtam estimate
- Website
- sqy-therapeutics.com
SQY Therapeutics at a glance
SQY Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Guyancourt, Île-de-France, France.
SQY Therapeutics was founded in 2015.
SQY Therapeutics has 11–50 employees.
SQY Therapeutics's revenue is $5.8M – $46.1M (Tamtam estimate).
Selling to companies like SQY Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies